Begin main content

Call for Patient Input and Clinical Experts: etonogestrel

August 16, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name TBD Generic name etonogestrel Manufacturer Merck Canada Inc. Indication(s) Prevention of pregnancy Project Number SR0629-000 Call for patient input 2019-08-16 Patient input deadlin...

Call for Patient Input and Clinical Experts: Cablivi

August 15, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Cablivi Generic name caplacizumab Manufacturer Sanofi-Genzyme, a division of sanofi-aventis Canada Inc. Indication(s) Acquired thrombotic thrombocytopenic purpura (aTTP) Project Number SR0633-000 ...

New at CADTH - August 2019

August 12, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Call for Patient Input and Clinical Experts: Taltz

August 1, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Taltz Generic name ixekizumab Manufacturer Eli Lilly Canada Inc. Indication(s) Ankylosing spondylitis Project Number SR0630-000 Call for patient input 2019-08-01 Patient input dead...

Pharmaceutical Reviews Update — Issue 9

July 31, 2019
See Pharmaceutical Reviews Update – Issue 9 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include: the announcement of CADTH’s new Patient and Community Advisory Committee opportunities for stakeholder comments and feedback on proposed updates to CADTH’s pharmaceutic...